Note 13 - Long-Term Debt (Details Textual) - FSA Travel, LLC [Member] - SBA EIDL Loan [Member] - USD ($) |
Apr. 09, 2025 |
Oct. 04, 2021 |
Aug. 31, 2026 |
Dec. 04, 2020 |
|---|---|---|---|---|
| Debt Instrument, Face Amount | $ 199,100 | $ 199,100 | $ 50,500 | |
| Debt Instrument, Interest Rate, Stated Percentage | 3.75% | |||
| Debt Instrument, Periodic Payment | 995 | $ 995 | ||
| Long-Term Debt, Fair Value | $ 98,920 | |||
| Debt Instrument, Interest Rate, Effective Percentage | 12.03% | |||
| Debt Instrument, Term (Month) | 299 months | |||
| Long-Term Debt, Gross | $ 97,804 |
| X | ||||||||||
- Definition Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Face (par) amount of debt instrument at time of issuance. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Contractual interest rate for funds borrowed, under the debt agreement. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of the required periodic payments including both interest and principal payments. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Period between issuance and maturity of debt instrument, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. No definition available.
|
| X | ||||||||||
- Definition The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|